Bridging Development and Disruption: Comprehensive Insights into Focal Cortical Dysplasia and Epileptic Management

Area of Science:

• Neurology
• Developmental Neuroscience
• Epileptology

Background:

• Focal cortical dysplasia (FCD) is a significant neurological disorder involving abnormal brain cell organization.
• It is a leading cause of drug-resistant epilepsy, particularly in pediatric and young adult populations.
• FCD research has advanced the understanding of epilepsy and cortical malformations.

Purpose of the Study:

• To provide a comprehensive narrative review of Focal Cortical Dysplasia.
• To highlight the association between FCD and drug-resistant epilepsy.
• To discuss diagnostic and therapeutic strategies, and future research directions.

Main Methods:

• Literature review of FCD, encompassing historical context, clinical presentation, diagnosis, and treatment.
• Exploration of diagnostic tools including electroencephalogram (EEG), microscopic evaluation, and 3T MRI epilepsy protocols.
• Review of therapeutic interventions, prognostic factors, and emerging treatments like the mTOR pathway.

Main Results:

• FCD presents a wide clinical spectrum, including varied seizures, cognitive deficits, and neuropsychiatric issues.
• Accurate diagnosis relies on a combination of clinical evaluation, EEG, neuroimaging (3T MRI), and histopathology.
• Treatment is individualized, ranging from anti-seizure medications to surgery for refractory cases.

Conclusions:

• FCD represents a complex interplay between brain development anomalies and epileptogenicity.
• Early and accurate diagnosis, alongside tailored treatment strategies, is crucial for managing FCD.
• Further research, particularly into pathways like mTOR, holds promise for improved therapeutic outcomes.